| Financial Year |
March 31 2023 |
| Monetary Funds |
10,312,423,528.99 |
| Held-for-trading Financial Assets |
400,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
23,783,385,362.06 |
| Advances to Suppliers |
1,629,030,653.80 |
| Other Receivables |
2,571,038,288.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,468,985.37 |
| Dividend Receivable |
395,244,134.93 |
| Inventories |
11,630,406,289.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
647,155,277.97 |
| Other Current Assets |
2,140,285,928.20 |
| Total Current Assets |
56,997,018,453.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,848,292,010.05 |
| Long-term Equity Investment |
5,392,358,706.51 |
| Investment Properties |
9,460,174.35 |
| Fixed Assetes |
28,937,409,397.52 |
| Under-construction Projects |
7,061,183,062.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,995,521,392.98 |
| R&D expenses |
390,327,939.56 |
| Goodwill |
178,171,370.24 |
| Long-Term Deferred and Prepaid Expenses |
77,304,278.88 |
| Deferred Income Tax Assets |
3,248,597,260.38 |
| Other Non-Current Assets |
11,911,371,996.85 |
| Sub-Total of Non-Current Assets |
72,787,301,266.97 |
| Total Assets |
129,784,319,720.80 |
| Short-Term Loans |
1,097,020,031.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,565,826,891.06 |
| Accounts Payable |
19,966,320,873.16 |
| Accounts Received In Advance |
15,487,397.34 |
| Employee Compensation Payable |
841,399,150.66 |
| Taxes Payable |
855,440,037.21 |
| Interest Payable |
2,509,863.07 |
| Dividend Payable |
113,731,514.38 |
| Other payables |
1,773,673,259.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,151,166,579.40 |
| Other Current Liabilities |
10,503,530.65 |
| Sub-Total of Current Liabilities |
52,821,177,961.18 |
| Long-term Loans |
26,330,628,576.46 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,940,257,508.69 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,877,867,646.31 |
| Deferred Income Tax Liabilities |
1,015,357,315.22 |
| Other Non-Current Liabilities |
143,182,931.78 |
| Sub-Total of Non-Current Liabilities |
35,343,184,906.39 |
| Total Liabilities |
88,164,362,867.57 |
| Paid-In Capital(Or Share Stock) |
4,225,067,647.00 |
| Capital Surplus |
12,148,077,471.66 |
| Surplus Reserve |
1,723,378,755.52 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
18,144,639,518.03 |
| Minority Stockholder's Interest |
2,294,280,769.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
39,325,676,083.61 |
| Owner's Equity（Stockholder's Equity） |
41,619,956,853.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
129,784,319,720.80 |
